Clinical Trials Browser

Recruiting × Neoplasms × mirvetuximab soravtansine × Clear all

NCT05445778 2026-02-23

GLORIOSA

Phase 3 Recruiting

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms